H.C. Wainwright Downgrades Kalvista Pharmaceuticals Inc (KALV) to Neutral

May 1, 2026 6:05 AM

H.C. Wainwright analyst Andrew Fein downgraded Kalvista Pharmaceuticals Inc (NASDAQ: KALV) from Buy to Neutral.The analyst comments "What’s new? KALV ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found